lutein has been researched along with Wet Macular Degeneration in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 19 (90.48) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Agrón, E; Antoszyk, AN; Chew, EY; Clemons, TE; Domalpally, A; Elman, MJ; Keenan, TD; Vitale, S | 1 |
| Agrón, E; Chew, EY; Cukras, CA; Domalpally, A; Hwang, CK; Keenan, TDL; Wong, WT | 1 |
| Cennamo, G; Cesarano, I; Eidenberger, T; Forte, R; Napolitano, A; Panzella, L | 1 |
| Bron, A; Chêne, G; Creuzot-Garcher, C; Delcourt, C; Delyfer, MN; Korobelnik, JF; Merle, BMJ; Rougier, MB; Savel, H | 1 |
| Beatty, S; Chakravarthy, U; Muldrew, KA; Nolan, JM; Stevenson, MR; Woodside, J | 1 |
| Ziegler, R | 1 |
| Musch, DC | 1 |
| Agrón, E; Antoszyk, AN; Bernstein, PS; Blodi, BA; Bressler, SB; Chandra, SR; Chew, EY; Clemons, TE; Danis, RP; Domalpally, A; Elman, MJ; Ferris, FL; Fish, GE; Friberg, T; Hubbard, GB; Klein, ML; Orth, D; Rosenfeld, PJ; Ruby, AJ; Sangiovanni, JP; Sperduto, RD; Toth, CA; Wong, WT | 1 |
| Benke, KE; Benke, KK | 1 |
| Chew, EY; Clemons, TE | 2 |
| Downie, LE; Keller, PR | 1 |
| Agrón, E; Al-Holou, SN; Chew, EY; Clemons, TE; Cukras, C; Ferris, FL; Tucker, WR | 1 |
| Chew, EY; Clemons, TE; Cukras, CA; Danis, RP; Domalpally, A; Friberg, TR; Sadda, SR; Toth, CA | 1 |
| Bron, A; Buaud, B; Creuzot-Garcher, C; Delcourt, C; Delyfer, MN; Korobelnik, JF; Merle, BMJ; Rougier, MB; Savel, H; Vaysse, C | 1 |
| Chakravarthy, U; Grattan, J; Lai, Y; Muldrew, A; Shi, Y; Young, G | 1 |
| Kontadakis, G; Makridaki, M; Moschandreas, J; Plainis, S; Tsika, C; Tsilimbaris, MK | 1 |
| Dou, HL; Huang, YB; Huang, YM; Lin, XM; Ma, L; Wu, YQ; Xu, XR; Zou, ZY | 1 |
| Biswas, S; Gupta, A; Raman, R | 1 |
| Aragón, JA; Olea, JL; Tur, JA; Zapata, ME | 1 |
| Biswas, S; Raman, R; Sharma, T; Vaitheeswaran, K | 1 |
1 review(s) available for lutein and Wet Macular Degeneration
| Article | Year |
|---|---|
Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
Topics: Age of Onset; Aged; Diet; Evidence-Based Medicine; Humans; Lutein; Macular Degeneration; Middle Aged; Risk; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2012 |
10 trial(s) available for lutein and Wet Macular Degeneration
| Article | Year |
|---|---|
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Female; Follow-Up Studies; Humans; Intravitreal Injections; Lutein; Male; Middle Aged; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2020 |
Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Follow-Up Studies; Geographic Atrophy; Humans; Lutein; Macula Lutea; Male; Middle Aged; Prospective Studies; Treatment Outcome; Wet Macular Degeneration; Zeaxanthins | 2021 |
Epilutein for Early-Stage Age-Related Macular Degeneration: A Randomized and Prospective Study.
Topics: Administration, Oral; Aged; Dietary Supplements; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Male; Middle Aged; Prospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Wet Macular Degeneration; Xanthophylls | 2017 |
Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Topics: Adult; Aged; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Pigment; Male; Middle Aged; Ophthalmoscopy; Retrospective Studies; Treatment Outcome; Visual Acuity; Vitamins; Wet Macular Degeneration; Zeaxanthins | 2017 |
Visual outcome after antioxidant supplementation.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; Double-Blind Method; Drug Therapy, Combination; Geographic Atrophy; Gluconates; Humans; Lutein; Middle Aged; Trace Elements; Treatment Outcome; Visual Acuity; Vitamin E; Wet Macular Degeneration; Xanthophylls; Zeaxanthins; Zinc Oxide | 2013 |
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
Topics: Administration, Oral; Aged; Aged, 80 and over; beta Carotene; Diet; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Retinal Drusen; Trace Elements; Treatment Outcome; Visual Acuity; Vitamins; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2014 |
The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Disease Progression; Fatty Acids, Omega-3; Female; Follow-Up Studies; Geographic Atrophy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lutein; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2015 |
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Grou
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Optical Imaging; Prospective Studies; Retina; Retinal Drusen; Retinal Pigment Epithelium; Tomography, Optical Coherence; Wet Macular Degeneration; Zeaxanthins | 2017 |
Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
Topics: Adult; Aged; Biomarkers; Chromatography, Gas; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Lutein; Macular Pigment; Male; Middle Aged; Pedigree; Prognosis; Prospective Studies; Wet Macular Degeneration; Zeaxanthins | 2017 |
Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Double-Blind Method; False Negative Reactions; Humans; Lutein; Predictive Value of Tests; Tomography, Optical Coherence; Vision Disorders; Visual Acuity; Visual Field Tests; Vitamin E; Wet Macular Degeneration; Xanthophylls; Zeaxanthins; Zinc | 2011 |
10 other study(ies) available for lutein and Wet Macular Degeneration
| Article | Year |
|---|---|
[Supplementary carotinoids and omega-3-fatty acids are ineffective].
Topics: Aged; Aged, 80 and over; Carotenoids; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Lutein; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2013 |
Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration.
Topics: Female; Humans; Lutein; Male; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2014 |
Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration.
Topics: Female; Humans; Lutein; Male; Wet Macular Degeneration; Xanthophylls | 2014 |
Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.
Topics: Female; Humans; Lutein; Male; Wet Macular Degeneration; Xanthophylls | 2014 |
Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial.
Topics: Female; Humans; Lutein; Male; Wet Macular Degeneration; Xanthophylls | 2014 |
Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial-reply.
Topics: Female; Humans; Lutein; Male; Wet Macular Degeneration; Xanthophylls | 2014 |
Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Geographic Atrophy; Humans; Intraocular Pressure; Lutein; Male; Middle Aged; Photometry; Retinal Pigments; Visual Acuity; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2011 |
Re: Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Topics: Female; Geographic Atrophy; Humans; Lutein; Male; Retinal Pigments; Wet Macular Degeneration; Xanthophylls | 2012 |
[Characteristics of patients with wet age-related macular degeneration and low intake of lutein and zeaxanthin].
Topics: Aged; Antioxidants; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diet; Diet Records; Diet, Mediterranean; Dyslipidemias; Female; Humans; Lutein; Male; Micronutrients; Obesity; Prospective Studies; Spain; Vitamins; Wet Macular Degeneration; Xanthophylls; Zeaxanthins; Zinc | 2012 |
Macular pigment optical density in wet age-related macular degeneration among Indians.
Topics: Adult; Aged; Aged, 80 and over; Densitometry; Diet; Female; Follow-Up Studies; Humans; India; Lutein; Male; Middle Aged; Retinal Pigments; Surveys and Questionnaires; Visual Acuity; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2012 |